Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32673139 | 0.82 | TSHR (0.37) | AKR1B1 | |
| SCHEMBL32673144 | 0.79 | TSHR (0.30) | — | |
| SCHEMBL32673010 | 0.76 | AKR1B1 (0.31) | AKR1B1 | |
| SCHEMBL32672943 | 0.76 | AKR1B1 (0.44) | AKR1B1 | |
| SCHEMBL20734708 | 0.74 | AKR1B1 (0.45) | AKR1B1 | |
| SCHEMBL32673038 | 0.71 | AKR1B1 (0.33) | AKR1B1 | |
| SCHEMBL11477205 | 0.68 | PSMB5 (0.43) | AKR1B1 | |
| SCHEMBL32672799 | 0.68 | — | — | |
| SCHEMBL31659494 | 0.68 | AKR1B1 (0.31) | AKR1B1 | |
| SCHEMBL32673040 | 0.68 | KDM4E (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260041798-A1 | RADIOPAQUE HYDROLYSABLE HYDROGELS AND METHODS OF TREATMENT USING SAME | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260041798-A1 | RADIOPAQUE HYDROLYSABLE HYDROGELS AND METHODS OF TREATMENT USING SAME | IDE, PAM, IDUA | AKR1B1 4319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.